Volume 19 - Issue 11 - November 2022
Insights
Interview
12/07/2022
Nathan Fagan, MD
Interventional Radiologist
Nationwide Children's Hospital, Columbus, Ohio
Nathan Fagan, MD
Interventiona...
Vascular Disease Management speaks with Interventional Radiologist Nathan Fagan, MD, from Nationwide Children’s Hospital in Columbus, Ohio, about using the ARTIS icono in the interventional pediatric space.
Vascular Disease Management speaks with Interventional Radiologist Nathan Fagan, MD, from Nationwide Children’s Hospital in Columbus, Ohio, about using the ARTIS icono in the interventional pediatric space.
Vascular Disease Management...
12/07/2022
Vascular Disease Management
Video
11/16/2022
Matthew Finn, MD, MSc, and Craig Walker, MD
Cardiovascular Institute of the South, Houma, Louisiana
Matthew Finn, MD, MSc, and Craig Walk...
Dr. Matthew Finn discusses the results of the just-released BEST-CLI trial.
Dr. Matthew Finn discusses the results of the just-released BEST-CLI trial.
Dr. Matthew Finn discusses the...
11/16/2022
Vascular Disease Management
Commentary
11/16/2022
Monica Majumdar, MD, MPH; Anahita Dua, MD, MS, MBA, FACS
Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
Monica Majumdar, MD, MPH; Anahita Dua...
Can we delineate objective differences in responsiveness to antiplatelet medications between the sexes to explain why women with PAD have fewer risk factors yet higher rates of nonhealing and amputation?
Can we delineate objective differences in responsiveness to antiplatelet medications between the sexes to explain why women with PAD have fewer risk factors yet higher rates of nonhealing and amputation?
Can we delineate objective...
11/16/2022
Vascular Disease Management
Column
Editor's Corner
11/16/2022
Matthew Finn, MD, MSc, and Craig Walker, MD
Cardiovascular Institute of the South, Houma, Louisiana
Matthew Finn, MD, MSc, and Craig Walk...
Drs. Finn and Walker discuss the results of the long-awaited BEST-CLI randomized control trial, which was presented at the American Heart Association’s 2022 Scientific Sessions in November.
Drs. Finn and Walker discuss the results of the long-awaited BEST-CLI randomized control trial, which was presented at the American Heart Association’s 2022 Scientific Sessions in November.
Drs. Finn and Walker discuss the...
11/16/2022
Vascular Disease Management
Feature
OBL Corner
11/16/2022
Sarah Melvin, MSPH; Pradeep Nair, MD
Cardiovascular Institute of the South, Houma, Louisiana
Sarah Melvin, MSPH; Pradeep Nair, MD
...
A review of the safety, efficacy, and outcomes of lower extremity endovascular intervention in patients with symptomatic PAD.
A review of the safety, efficacy, and outcomes of lower extremity endovascular intervention in patients with symptomatic PAD.
A review of the safety,...
11/16/2022
Vascular Disease Management
